Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Eustachian Tube Dysfunction: early-phase trial registry
1 of 3 indexed Eustachian Tube Dysfunction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Eustachian Tube Dysfunction: 3 US clinical trials tracked, 1 recruiting.
Eustachian Tube Dysfunction is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Cuneyt M. Alper, running 1 of these trials.
Enrollment posture brief
Registry condition eustachian-tube-dysfunction
OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Eustachian Tube Dysfunction lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Eustachian Tube Dysfunction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Eustachian Tube Dysfunction is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD)
Cedars-Sinai Medical Center
NCT05275686
SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure
Medical University of South Carolina
NCT04404036
Tubomanometry and EarPopper Devices for Eustachian Tube Function Testing
Cuneyt M. Alper
NCT03850197
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Eustachian Tube Dysfunction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Eustachian Tube Dysfunction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Eustachian Tube Dysfunction page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Eustachian Tube Dysfunction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cuneyt M. Alper sponsors the most Eustachian Tube Dysfunction trials on record, review their full trial history before evaluating a specific study. See Cuneyt M. Alper's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Eustachian Tube Dysfunction condition card totals 3 registered trials; most-linked intervention Tubomanometry; top US site state South Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.